Rankings
▼
Calendar
CORT (Corcept Therapeutics Incorporated) Stock Financials & Earnings | Market Cap Arena
CORT
Corcept Therapeutics Incorporated
Mkt Cap
$4B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$761M
Net Income (TTM)
$99M
EPS (TTM)
$0.82
Free Cash Flow (TTM)
$142M
Gross Margin
98.3%
Op. Margin
5.9%
Net Margin
13.0%
FCF Margin
18.6%
P/S Ratio (TTM)
4.7x
P/E Ratio (TTM)
35.8x
YoY Rev Growth
+12.8%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$106M
$104M
$15M
Q2 23
$118M
$116M
$30M
Q3 23
$124M
$122M
$31M
Q4 23
$135M
$134M
$32M
Q1 24
$147M
$144M
$30M
Q2 24
$164M
$161M
$36M
Q3 24
$183M
$180M
$47M
Q4 24
$182M
$179M
$25M
Q1 25
$157M
$155M
$3M
Q2 25
$194M
$191M
$27M
Q3 25
$208M
$203M
$10M
Q4 25
$202M
$200M
$4M
marketcaparena.com
Revenue Breakdown
CORT
Corcept Therapeutics Incorporated
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
8.6x
37.6x
Q2 23
8.3x
37.5x
Q3 23
7.9x
38.8x
Q4 23
7.4x
33.4x
Q1 24
6.8x
30.1x
Q2 24
6.2x
28.2x
Q3 24
5.6x
25.1x
Q4 24
5.3x
25.3x
Q1 25
5.2x
26.7x
Q2 25
5.0x
26.8x
Q3 25
4.8x
33.7x
Q4 25
4.7x
35.8x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$26M
$26M
Q2 23
$42M
$42M
Q3 23
$53M
$53M
Q4 23
$6M
$6M
Q1 24
$24M
$24M
Q2 24
$41M
$41M
Q3 24
$74M
$72M
Q4 24
$59M
$59M
Q1 25
$5M
$5M
Q2 25
$44M
$44M
Q3 25
$54M
$54M
Q4 25
$38M
$38M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$102K
Q3 23
$37K
Q4 23
$0
Q1 24
$0
Q2 24
$416K
Q3 24
$2M
Q4 24
$121K
Q1 25
$104K
Q2 25
$57K
Q3 25
$0
Q4 25
$50K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+12.8%
+35.7%
Q2 23
+13.9%
+22.5%
Q3 23
+21.5%
+32.4%
Q4 23
+31.4%
+28.8%
Q1 24
+39.0%
+29.2%
Q2 24
+39.1%
+45.5%
Q3 24
+47.7%
+47.1%
Q4 24
+34.3%
+51.0%
Q1 25
+7.1%
+31.1%
Q2 25
+18.7%
+30.9%
Q3 25
+13.7%
+45.2%
Q4 25
+11.1%
+26.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$11M
10.5%
Q2 23
$12M
10.1%
Q3 23
$13M
10.4%
Q4 23
$13M
9.6%
Q1 24
$13M
9.0%
Q2 24
$0
0.0%
Q3 24
$0
0.0%
Q4 24
$17M
9.2%
Q1 25
$22M
13.9%
Q2 25
$19M
9.8%
Q3 25
$0
0.0%
Q4 25
-$64M
-31.5%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$41M
$49M
Q2 23
$43M
$43M
Q3 23
$46M
$45M
Q4 23
$55M
$47M
Q1 24
$59M
$56M
Q2 24
$59M
$67M
Q3 24
$59M
$74M
Q4 24
$70M
$83M
Q1 25
$61M
$91M
Q2 25
$60M
$104M
Q3 25
$69M
$124M
Q4 25
$65M
$130M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$300M
$165M
$465M
Q2 23
$172M
$191M
$363M
Q3 23
$112M
$243M
$355M
Q4 23
$136M
$233M
$368M
Q1 24
$150M
$261M
$411M
Q2 24
$129M
$345M
$473M
Q3 24
$137M
$243M
$380M
Q4 24
$128M
$256M
$383M
Q1 25
$90M
$233M
$323M
Q2 25
$103M
$239M
$342M
Q3 25
$125M
$297M
$422M
Q4 25
$120M
$252M
$372M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
115M
-0.8%
Q2 23
110M
-5.1%
Q3 23
111M
+1.4%
Q4 23
111M
-0.2%
Q1 24
110M
-0.9%
Q2 24
111M
+1.2%
Q3 24
114M
+2.2%
Q4 24
118M
+4.2%
Q1 25
120M
+1.1%
Q2 25
120M
+0.6%
Q3 25
119M
-0.9%
Q4 25
120M
+0.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$531K
50
FY 15
$645K
78
FY 16
$790K
103
FY 17
$1M
136
FY 18
$2M
166
FY 19
$1M
206
FY 20
$1M
236
FY 21
$2M
238
FY 22
$1M
299
FY 23
$1M
352
FY 24
$1M
500
FY 25
$1M
730
marketcaparena.com